Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial (Q33413609)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial |
scientific article |
Statements
1 reference
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial (English)
1 reference
Gennaro Cormio
1 reference
Pierluigi Benedetti Panici
0 references
Maria Carmela Piccirillo
1 reference
Dionyssios Katsaros
1 reference
Giovanni Scambia
1 reference
Ciro Gallo
1 reference
Sabino De Placido
1 reference
Alessandra Bologna
1 reference
Beatrice Weber
1 reference
Francesco Raspagliesi
1 reference
Roberto Sorio
1 reference
Maria Giovanna Cavazzini
1 reference
Gabriella Ferrandina
1 reference
Enrico Breda
1 reference
Viviana Murgia
1 reference
Cosimo Sacco
1 reference
Saverio Cinieri
1 reference
Vanda Salutari
1 reference
Carmela Pisano
1 reference
Stefano Greggi
1 reference
Rossella Lauria
1 reference
Luigi Selvaggi
1 reference
Simona Signoriello
1 reference
Francesco Perrone
1 reference
Multicentre Italian Trials in Ovarian cancer (MITO-7)
1 reference
Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO)
1 reference
Mario Negri Gynecologic Oncology (MaNGO)
1 reference
European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10)
1 reference
Gynecologic Cancer InterGroup (GCIG) Investigators
1 reference
28 February 2014
1 reference
1 reference
Identifiers
1 reference